Immunovant

$42.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.58 (+1.39%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Immunovant and other stocks, options, and ETFs commission-free!

About IMVT

Immunovant, Inc. Common Stock, also called Immunovant, is a clinical-stage biopharmaceutical company. It focuses on enabling normal lives for patients with autoimmune diseases. The company was founded in 2018 and is headquartered in New York, NY. The listed name for IMVT is Immunovant, Inc. Common Stock.

CEO
Peter Salzmann
Employees
—
Headquarters
New York, New York
Founded
2018
Market Cap
4.22B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
437.05K
High Today
$43.55
Low Today
$41.25
Open Price
$41.25
Volume
333.38K
52 Week High
$53.75
52 Week Low
$8.34

Collections

IMVT Earnings

-$0.38
-$0.25
-$0.13
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Mar 29, Pre-Market

You May Also Like

NYMTP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure